Novartis AG
Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules

Last updated:

Abstract:

The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising these molecules, and methods of using and producing these molecules.

Status:
Grant
Type:

Utility

Filling date:

8 May 2018

Issue date:

18 Aug 2020